House hearing shows Biden FDA prioritized politics over safety in approving COVID vaccine for kids and military personnel
During a recent House Judiciary subcommittee hearing, the focus was on the ‘politicization’ of the U.S. Food and Drug Administration (FDA) during the COVID-19 pandemic. Shocking revelations exposed how the Biden administration may have pressured medical professionals to hasten the approval of the COVID-19 vaccine for children without sufficient testing to guarantee its safety.
Chairman Thomas Massie, R-Ky., opened the hearing titled “Follow the Science?: Oversight of the Biden COVID-19 Administrative State Response” with disturbing testimony from Dr. Marion Gruber, former director of the FDA’s vaccine office. Gruber had expressed the need for more trial testing, especially among males aged 12 to 17, before licensing the vaccines. However, Dr. Peter Marks, the agency’s top vaccine regulator, allegedly pushed to speed up the process for vaccination mandates despite serious side effects like myocarditis and pericarditis emerging.
Rep. Massie highlighted the urgency to study the effects of these vaccines further. Massie criticized Marks for firing top vaccine officials who wanted more time to assess the vaccines properly and removing them from their duties to rush the approval process. The decision to mandate vaccines, particularly for children, was questioned due to a lack of proper testing and emerging reports of vaccine injuries.
Dr. Jordan Vaughn, an internist from Alabama, shared his concerns at the hearing, stating that vaccine hesitancy arose due to misinformation from the government about COVID-19 and the vaccines. He recounted treating over 2,000 patients with complications from the COVID-19 vaccination, including more than 30 service members.
Several examples were provided where vaccinated individuals, including service members, suffered adverse effects such as hospitalization, emergency surgeries, and even death. Vaughn emphasized the loss of trust in the medical and public health systems among those who experienced vaccine injuries, leading to shattered faith and severe consequences.
Witness Aaron Siri, a vaccine litigation expert, highlighted the financial conflicts of interest faced by pharmaceutical companies rolling out these vaccines. He mentioned that immunity clauses protected these companies from accountability for vaccine injuries, leading to rushed approvals and inadequate safety measures.
Another witness, Dr. Philip Krause, former Deputy Director at the FDA Office of Vaccines Research & Review, resigned from the agency in protest over political pressure to authorize vaccine boosters for young people. He expressed concerns over the rapid move to mandates, suggesting that political interests influenced decisions more than public health considerations.
The hearing shed light on how political influences jeopardize public trust in the FDA and other public health agencies. By prioritizing mandates over proper testing protocols, the Biden administration faced criticism for putting potential political gains ahead of public health safety.
As the debate continues on the safety and efficacy of COVID-19 vaccines, it is crucial to ensure transparency, accountability, and public health-driven decision-making to regain trust and address vaccine hesitancy among the population.
